These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 1759975)

  • 1. Gene expression, cellular diversification and tumor progression to the metastatic phenotype.
    Nicolson GL
    Bioessays; 1991 Jul; 13(7):337-42. PubMed ID: 1759975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative variations in gene expression: possible role in cellular diversification and tumor progression.
    Nicolson GL
    J Cell Biochem; 1991 Aug; 46(4):277-83. PubMed ID: 1757473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastasis-Associated genes and metastatic tumor progression.
    Nicolson GL; Moustafa AS
    In Vivo; 1998; 12(6):579-88. PubMed ID: 9891220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of cancer metastasis: tumor and host properties and the role of oncogenes and suppressor genes.
    Nicolson GL
    Curr Opin Oncol; 1991 Feb; 3(1):75-92. PubMed ID: 2043698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer metastasis-associated genes: role in tumour progression to the metastatic state.
    Nicolson GL
    Biochem Soc Symp; 1998; 63():231-43. PubMed ID: 9513727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression.
    Nicolson GL
    Cancer Res; 1987 Mar; 47(6):1473-87. PubMed ID: 3545445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfection of activated c-H-rasEJ/pSV2neo or pSV2neo genes into rat mammary cells: rapid stimulation of clonal diversification of spontaneous metastatic and cell-surface properties.
    Nicolson GL; Gallick GE; Spohn WH; Lembo TM; Tainsky MA
    Oncogene; 1992 Jun; 7(6):1127-35. PubMed ID: 1594244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic regulation of metastatic progression.
    Wright JA; Egan SE; Greenberg AH
    Anticancer Res; 1990; 10(5A):1247-55. PubMed ID: 2241100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
    Su ZZ; Austin VN; Zimmer SG; Fisher PB
    Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
    Spandidos DA
    Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of glycosphingolipids in the expression of neoplastic phenotype. III. Changes in glycosphingolipids related to the capacity of neoplastic cells for metastasis and tumor growth in vivo].
    Ugorski M
    Postepy Hig Med Dosw; 1992; 46(2):191-208. PubMed ID: 1470581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of hst gene expression with metastatic phenotype in mouse mammary tumors.
    Murakami A; Tanaka H; Matsuzawa A
    Cell Growth Differ; 1990 May; 1(5):225-31. PubMed ID: 1964796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor cell progression and differentiation in metastasis.
    Hart IR; Easty D
    Semin Cancer Biol; 1991 Apr; 2(2):87-95. PubMed ID: 1912522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transformation effector and suppressor genes.
    Boylan MO; Zarbl H
    J Cell Biochem; 1991 Jul; 46(3):199-205. PubMed ID: 1774222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MHC class I genes controlling the metastatic phenotype of tumor cells.
    Feldman M; Eisenbach L
    Semin Cancer Biol; 1991 Oct; 2(5):337-46. PubMed ID: 1773049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogene transformation and the metastatic phenotype.
    Chambers AF; Tuck AB
    Anticancer Res; 1988; 8(5A):861-71. PubMed ID: 3052258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrinsic or acquired drug resistance and metastasis: are they linked phenotypes?
    Kerbel RS; Kobayashi H; Graham CH
    J Cell Biochem; 1994 Sep; 56(1):37-47. PubMed ID: 7806590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogene activation and tumor suppressor gene inactivation during multistage mouse skin carcinogenesis.
    Bowden GT; Schneider B; Domann R; Kulesz-Martin M
    Cancer Res; 1994 Apr; 54(7 Suppl):1882s-1885s. PubMed ID: 8137304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural selection and early changes of phenotype of tumor cells in vivo: acquisition of new defense mechanisms.
    Deichman GI
    Biochemistry (Mosc); 2000 Jan; 65(1):78-94. PubMed ID: 10702643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.